Home › Funds › WYNNEFIELD CAPITAL INC › LFCR

WYNNEFIELD CAPITAL INC position in LFCR

LIFECORE BIOMEDICAL INC · Health Care

WYNNEFIELD CAPITAL INC reported holding 4,867,816 shares of LFCR (LIFECORE BIOMEDICAL INC) in its Q3 2026 13F filing — a position valued at US$32.0M, representing 26.30% of its reported portfolio and ranking #1 among its reported holdings. WYNNEFIELD CAPITAL INC has disclosed LFCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)4.87M sh
Reported value held$32.03M
Portfolio Weight26.30%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How WYNNEFIELD CAPITAL INC's LFCR position evolved

WYNNEFIELD CAPITAL INC first disclosed a stake in LFCR in Q3 2023 at 4,923,545 shares (US$37.1M). The position peaked in Q4 2025 at 4,703,216 shares, worth US$38.5M. Across 13 filings, WYNNEFIELD CAPITAL INC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 4,867,816 shares valued at US$32.0M — an increase of 164,600 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.92M $37.15M New
Q4 2023 4.92M $30.48M Hold
Q1 2024 4.92M $26.14M Hold
Q2 2024 4.92M $25.23M Hold
Q3 2024 4.92M $24.25M Hold
Q4 2024 4.70M $34.94M Reduce
Q1 2025 4.70M $33.11M Hold
Q2 2025 4.70M $38.19M Hold
Q3 2025 4.70M $34.62M Hold
Q4 2025 4.70M $38.47M Hold
Q1 2026 4.70M $17.50M Hold
Q2 2026 4.70M $24.69M Hold
Q3 2026 4.87M $32.03M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LFCR and 13F data

LFCR (LIFECORE BIOMEDICAL INC) is a Health Care company. 23 other funds we track also report a position in LFCR — the largest reported positions include Legion Partners Asset Management, LLC (US$29.5M), 325 CAPITAL LLC (US$19.1M), Greenhaven Road Investment Management, L.P. (US$18.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LFCR

All LFCR fund holders →

FAQ

How long has WYNNEFIELD CAPITAL INC held LFCR?

WYNNEFIELD CAPITAL INC has disclosed LFCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WYNNEFIELD CAPITAL INC's current position in LFCR?

As of Q3 2026, WYNNEFIELD CAPITAL INC holds 4.87M shares of LFCR (LIFECORE BIOMEDICAL INC), valued at $32.03M, representing 26.30% of its reported portfolio and ranking #1.

Has WYNNEFIELD CAPITAL INC been buying or selling LFCR?

In the latest 13F filing (Q3 2026), WYNNEFIELD CAPITAL INC increased its position in LFCR. The position peaked in Q4 2025 at 4.70M shares.

Which other funds hold LFCR?

Other major institutional holders of LFCR include Legion Partners Asset Management, LLC, 325 CAPITAL LLC, Greenhaven Road Investment Management, L.P., among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.